{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:29:07Z","timestamp":1745555347975},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbiotec.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T23:38:54Z","timestamp":1716939534000},"page":"20-32","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach"],"prefix":"10.1016","volume":"391","author":[{"given":"Eleon\u00f3ra","family":"G\u00e1l","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanda","family":"Mikl\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lajos","family":"Kem\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Ver\u00e9b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria","family":"Venglovecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2024.05.010_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic ductal adenocarcinoma: current and evolving therapies","author":"Adamska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib2","doi-asserted-by":"crossref","unstructured":"Adolph, T.E., Mayr, L., Grabherr, F., Schw\u00e4rzler, J., Tilg, H., 2019. Pancreas \u2013 Microbiota Cross Talk in Health and Disease.","DOI":"10.1146\/annurev-nutr-082018-124306"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.10.031","article-title":"Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential","volume":"370","author":"Alasmael","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.tiv.2012.12.020","article-title":"Bile acids in the colon, from healthy to cytotoxic molecules","volume":"27","author":"Barrasa","year":"2013","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib5","doi-asserted-by":"crossref","DOI":"10.1159\/000495324","article-title":"Minimally invasive surgery of pancreatic cancer: feasibility and rationale","author":"Bausch","year":"2018","journal-title":"Visc. Med."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","author":"Bertolini","year":"2022","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.00397","article-title":"Tumor microenvironment: extracellular matrix alterations influence tumor progression","volume":"10","author":"Brassart-Pasco","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108990","article-title":"Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer","volume":"35","author":"Carstens","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib10","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.5604\/01.3001.0010.5501","article-title":"Bile acids and cancer: direct and environmental-dependent effects","volume":"16","author":"Ciaula","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","author":"Deer","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib12","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v22.i33.7463","article-title":"Role of bile acids in carcinogenesis of pancreatic cancer: an old topic with new perspective","author":"Feng","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79181-6","article-title":"Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4","volume":"10","author":"G\u00e1l","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib14","first-page":"1","article-title":"Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib15","article-title":"Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer","volume":"6","author":"Han","year":"2015","journal-title":"Particip. Charact."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib16","first-page":"4288","article-title":"SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer","author":"Harris","year":"2017","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1060957","article-title":"Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: key role of the urokinase plasminogen activator (PLAU)","volume":"13","author":"Hosen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib18","first-page":"33265","article-title":"Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer","volume":"8","author":"Hu","year":"2017","journal-title":"A Study Based TCGA Tissue Micro"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2018.11.023","article-title":"Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma","author":"Igbinigie","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.lpm.2019.02.027","article-title":"Pancreatic cancer surgical management","volume":"48","author":"Jeune","year":"2019","journal-title":"Presse Med."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.molonc.2016.04.007","article-title":"Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer","volume":"10","author":"Joshi","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib22","doi-asserted-by":"crossref","DOI":"10.4172\/2165-7092.1000163","article-title":"Serum level of Urokinase plasminogen activator (uPA) correlates with the survival of patients with pancreatic ductal adenocarcinoma (PDAC)","volume":"05","author":"K","year":"2015","journal-title":"Pancreat. Disord. Ther."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib23","doi-asserted-by":"crossref","unstructured":"Kainuma, M., Takada, I., Makishima, M., Sano, K., 2018. Farnesoid X Receptor Activation Enhances Transforming Growth Factor \u03b2 -Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells 1\u20139. https:\/\/doi.org\/10.3390\/ijms19071898.","DOI":"10.3390\/ijms19071898"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib24","doi-asserted-by":"crossref","unstructured":"Kanno, A., Masamune, A., Hanada, K., Kikuyama, M., n.d. Advances in Early Detection of Pancreatic Cancer 2018, 1\u201311. https:\/\/doi.org\/10.3390\/diagnostics9010018.","DOI":"10.3390\/diagnostics9010018"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020152","article-title":"The Urokinase plasminogen activation system in pancreatic cancer: prospective diagnostic and therapeutic targets","author":"Kumar","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib26","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ijc.26293","article-title":"Expression of the nuclear bile acid receptor\/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis","volume":"130","author":"Lax","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/bjc.2011.37","article-title":"Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion","volume":"104","author":"Lee","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1030-y","article-title":"Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib29","first-page":"1","article-title":"Serum total bile acids in relation to gastrointestinal cancer risk","volume":"12","author":"Li","year":"2022","journal-title":"A Retrosp. Study Demogr. Charact. Study"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib31","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1080\/15384101.2017.1356510","article-title":"The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma","volume":"16","author":"Liu","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6604650","article-title":"C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma","volume":"99","author":"Mahner","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib34","doi-asserted-by":"crossref","unstructured":"Malhotra, P., Palanisamy, R., Caparros-martin, J.A., 2023. Bile acids and microbiota interplay in pancreatic cancer 1\u201332.","DOI":"10.3390\/cancers15143573"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2017.01.006","article-title":"Bile acids and their receptors","volume":"56","author":"Martinot","year":"2017","journal-title":"Mol. Asp. Med"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/j.gastro.2013.08.008","article-title":"Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis","volume":"145","author":"Matsuzaki","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib37","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-13-2329","article-title":"Novel mechanistic insights into ectodomain shedding of egfr ligands amphiregulin and TGF-\u03b1: impact on gastrointestinal cancers driven by secondary bile acids","volume":"74","author":"Nagathihalli","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib38","doi-asserted-by":"crossref","DOI":"10.2147\/CEG.S4343","article-title":"Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis","author":"Payne","year":"2008","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4610-4","article-title":"Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study","volume":"18","author":"Saad","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib41","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early detection of pancreatic cancer: opportunities","volume":"156","author":"Singhi","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/ijc.24865","article-title":"Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth","volume":"126","author":"Takahashi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3748\/wjg.v18.i3.244","article-title":"High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis","volume":"18","author":"Thummarati","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib44","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-15-0469","article-title":"The role of bile acids in metabolic regulation","author":"V\u00edtek","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6040","article-title":"Characters of KRT80 and its roles in neoplasms diseases","author":"Wei","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib46","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1074\/jbc.M114.620369","article-title":"MiR-22-silenced cyclin a expression in colon and liver cancer cells is regulated by bile acid receptor","volume":"290","author":"Yang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/2326-6066.CIR-17-0672","article-title":"Farnesoid X receptor constructs an immunosuppressive microenvironment and sensitizes FXRhighPD-L1low NSCLC to anti-PD-1 immunotherapy","volume":"7","author":"You","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jbiotec.2024.05.010_bib48","doi-asserted-by":"crossref","unstructured":"Yu, J., Zheng, J., Qi, J.I.E., Yang, K.U.I., Wu, Y., Wang, K.A.I., Wang, C., Sun, X., 2019. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR \/ NF- \u03ba B signalling pathway 879\u2013892. https:\/\/doi.org\/10.3892\/ijo.2019.4692.","DOI":"10.3892\/ijo.2019.4692"},{"key":"10.1016\/j.jbiotec.2024.05.010_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165624001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165624001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T02:06:35Z","timestamp":1719626795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165624001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S0168165624001500"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2024.05.010","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}